These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21499089)

  • 1. Liver function tests and statins.
    Zamor PJ; Russo MW
    Curr Opin Cardiol; 2011 Jul; 26(4):338-41. PubMed ID: 21499089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of statins in patients with liver disease.
    Kalaitzakis E; Björnsson ES
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):15-24. PubMed ID: 24632765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Statins: hepatotoxicity and monitoring].
    Cadranel JF; Seddik M; Loric S; Jeanne S
    Presse Med; 2009 May; 38(5):717-25. PubMed ID: 19111435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing statins to patients with nonalcoholic fatty liver disease: real cardiovascular benefits outweigh theoretical hepatotoxic risk.
    Riley P; Al Bakir M; O'Donohue J; Crook M
    Cardiovasc Ther; 2009; 27(3):216-20. PubMed ID: 19555426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant nonalcoholic fatty liver disease amelioration with rosuvastatin and pioglitazone combination therapy in a patient with metabolic syndrome.
    Riche DM; Fleming JW; Malinowski SS; Black CA; Miller KH; Wofford MR
    Ann Pharmacother; 2014 Jan; 48(1):137-41. PubMed ID: 24259612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins in liver disease: a molehill, an iceberg, or neither?
    Argo CK; Loria P; Caldwell SH; Lonardo A
    Hepatology; 2008 Aug; 48(2):662-9. PubMed ID: 18666246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease and statins.
    Tziomalos K; Athyros VG; Paschos P; Karagiannis A
    Metabolism; 2015 Oct; 64(10):1215-23. PubMed ID: 26234727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy.
    Tzefos M; Olin JL
    J Clin Lipidol; 2011; 5(6):450-9. PubMed ID: 22108148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of statins in patients with chronic hepatitis C.
    Andrus MR; East J
    South Med J; 2010 Oct; 103(10):1018-22; quiz 1023. PubMed ID: 20818300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver tests are irrelevant when prescribing statins.
    Bader T
    Lancet; 2010 Dec; 376(9756):1882-3. PubMed ID: 21109303
    [No Abstract]   [Full Text] [Related]  

  • 12. Considerations for safe use of statins: liver enzyme abnormalities and muscle toxicity.
    Gillett RC; Norrell A
    Am Fam Physician; 2011 Mar; 83(6):711-6. PubMed ID: 21404982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease and the statins treatment.
    Dima A; Marinescu AG; Dima AC
    Rom J Intern Med; 2012; 50(1):19-25. PubMed ID: 22788090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on drug induced liver injury.
    Rangnekar AS; Fontana RJ
    Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipid-lowering treatment and liver dysfunction].
    Gencer B; Moradpour D; Rodondi N
    Rev Med Suisse; 2012 Mar; 8(331):507-8, 510-2. PubMed ID: 22471112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits.
    Anfossi G; Massucco P; Bonomo K; Trovati M
    Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):215-24. PubMed ID: 15553600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hepatic injury associated with different statins in patients with chronic liver disease: a nationwide population-based cohort study.
    Chang CH; Chang YC; Lee YC; Liu YC; Chuang LM; Lin JW
    J Gastroenterol Hepatol; 2015 Jan; 30(1):155-62. PubMed ID: 25041076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stopping statins.
    Stone NJ
    Circulation; 2004 Oct; 110(16):2280-2. PubMed ID: 15492328
    [No Abstract]   [Full Text] [Related]  

  • 19. Statins: time to rationalise LFTs?
    Drug Ther Bull; 2017 May; 55(5):50. PubMed ID: 28465369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.
    Björnsson E; Jacobsen EI; Kalaitzakis E
    J Hepatol; 2012 Feb; 56(2):374-80. PubMed ID: 21889469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.